SetBone Medical Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

SetBone Medical Ltd - overview

Established

2017

Location

-, -, Israel

Primary Industry

Healthcare Specialists

About

Based in Israel, and founded in 2017, SetBone Medical Ltd. operates as a healthcare company that develops novel bone treatments. Group, with participation from other unspecified investors. The company was founded by its CEO Nimrod Kaufmann, who is a founder and previous CEO of Inspiro Medical Ltd.


, and, CTO Royi Kaufmann. In January 2022, SetBone Medical Ltd raised USD 1. 6 million in venture funding from new investors Agriline Ltd, Chicago ArchAngels II, LLC, and Trendlines Group. SetBone Medical has developed a new acrylic ready-to-use bone cement that, unlike its competitors, comes in a prefilled cartridge and contains no harmful monomers.


It can be used to treat orthopedic and spine operations such as vertebral compression fractures caused by osteoporosis. SetBone Medical Ltd plans to use the January funds to support the next stage of development and initiation of a First in Human pilot study.


Current Investors

Trendlines Group, Chicago ArchAngels II, LLC, Agriline Ltd

Primary Industry

Healthcare Specialists

Sub Industries

Chiropractic, Orthopedic & Physical Therapy

Website

www.setbone.com

Verticals

HealthTech, Manufacturing

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.